Cited by 62Nanoparticle-Based Drug DeliveryGlioma Diagnosis and TreatmentAdvanced Drug Delivery Systems

Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment

Open access
Luiz, Marcela Tavares, Viegas, Juliana Santos Rosa, Abriata, Juliana Palma, Tofani, Larissa Bueno, Vaidergorn, Miguel de Menezes, Emery, Flavio da Silva, Chorilli, Marlus, Marchetti, Juliana Maldonado·2021·Materials Science and Engineering: C

Abstract

Glioblastoma multiforme (GBM) is a first primary Central Nervous System tumor with high incidence and lethality. Its treatment is hampered by the difficulty to overcome the blood-brain barrier (BBB) and by the non-specificity of chemotherapeutics to tumor cells. This study was based on the development characterization and in vitro efficacy of folate-modified TPGS transfersomes containing docetaxel (TF-DTX-FA) to improve GBM treatment. TF-DTX-FA and unmodified transfersomes (TF-DTX) were prepared through thin-film hydration followed by extrusion technique and characterized by physicochemical and in vitro studies. All formulations showed low particles sizes (below 200 nm), polydispersity index below 0.2, negative zeta potential (between -16.75 to -12.45 mV) and high encapsulation efficiency (78.72 ± 1.29% and 75.62 ± 0.05% for TF-DTX and TF-DTX-FA, respectively). Furthermore, cytotoxicity assay of TF-DTX-FA showed the high capacity of the nanocarriers to reduce the viability of U-87 MG in both 2D and 3D culture models, when compared with DTX commercial formulation and TF-DTX. In vitro cellular uptake assay indicated the selectivity of transfersomes to tumoral cells when compared to normal cells, and the higher ability of TF-DTX-FA to be internalized into 2D U-87 MG in comparison with TF-DTX (72.10 and 62.90%, respectively, after 24 h). Moreover, TF-DTX-FA showed higher permeability into 3D U-87 MG spheroid than TF-DTX, suggesting the potential FA modulation to target treatment of GBM.

Integrity signals

Registry

Crossref · 10.1016/j.msec.2021.112033

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Folate receptor is overexpressed on the surface of a variety of cancers including breast, kidney, colorectal, brain, and ovarian cancers.

    “The folate receptor (FR) is overexpressed on the surface of a variety of cancers, including breast, kidney, colorectal, brain, and ovarian cancers.263–265”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [264]

Cites

Flagged first, then by citations

3 of the 56 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Luiz, M. T., Viegas, J. S. R., Abriata, J. P., Tofani, L. B., Vaidergorn, M. D. M., Emery, F. D. S., Chorilli, M., & Marchetti, J. M.
Affiliations
  • Universidade de São Paulo (BR)
  • Universidade Estadual Paulista (Unesp) (BR)
Corresponding author
Marchetti, Juliana Maldonado
Venue
Materials Science and Engineering: C
Publisher
Elsevier BV
Published
2021-05
Volume
124
Pages
112033
ISSN
0928-4931 (ISSN-L)
OpenAlex
W3136454776
Cited by
62
References
56
Citations by year
2026: 6 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 12 · 2021: 6
FWCI
3.01
Type
journal article
Language
en
Open access
Locations
  • Materials Science and Engineering C (publishedVersion)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Funders
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
glioblastoma, docetaxel, TPGS, blood-brain barrier, nanocarriers, drug delivery, U87 cells, cellular uptake, tumor spheroids, encapsulation efficiency, cytotoxicity
MeSH terms
Docetaxel, Antineoplastic Agents, Drug Carriers, Folic Acid, Glioblastoma, Humans, Vitamin E, Cell Line, Tumor, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review